Do you have the same question? Follow this Question
Feb 02, 2026 - 01:09 PM
We’ve provided several answers to questions related to Keytruda (Pembrolizumab) , see some other helpful Q&A related to this product.
Question: What infusion-related reactions might occur?
Answer: Infusion-related reactions can include hypersensitivity and anaphylaxis. Hypersensitivity is an allergic reaction, while anaphylaxis is a severe, potentially life-threatening reaction; knowing these risks is important for rapid response if symptoms occur.
Question: What is the active ingredient in this medication?
Answer: The active ingredient is pembrolizumab. Pembrolizumab is a type of immunotherapy that helps the immune system detect and fight cancer cells, which can be valuable for patients seeking advanced cancer treatments.
